bpc 157 case study Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review BPC-157: What It Is, What
Description
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study
Wieder: keine Kontrollgruppe, keine Verblindung
Manufacturing is done in FDA registered facilities with proper quality control protocols
Skincare peptides are becoming one of the most in-demand solutions in aesthetic medicine thanks to their ability to support firmer, smoother, and more radiant-looking skin
Which claims rest on human trials, which rest on rat studies, and what is unsafe.
Margolina, GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration, Wiley, 2015
